Status:
UNKNOWN
Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer
Lead Sponsor:
University Hospital, Limoges
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
In cervical cancer prognosis factors are size of the tumour, pelvic and para-aortic lymph nodes involvement. The initial treatment taking is determined by lymph node evaluation. Early stage cervical ...
Eligibility Criteria
Inclusion
- Patient with cervical carcinoma: histological proof of epidermoid carcinoma or of adenocarcinoma
- Stage I to IV (limited to pelvic) (FIGO Classification) (see appendix 3)
- Age ≥ 18 years old
- No contra-indication to surgery
- Dated, informed and signed consent from the patient
Exclusion
- Metastatic cervical cancer with extra-pelvic metastasis
- Contra-indication to MRI: implantation of an electronic device, metallic or ferromagnetic foreign body
- Serious co-existing affection with vital prognosis
- Diabetes uncontrolled by a classical treatment: glycaemia \> 1.4g/l
- Pregnancy and lactation
- Uncontrolled infection
- Other cancer within the previous 5 years, except skin basal cell carcinoma, or in situ cervical cancer
- Patient with some deficiency preventing her from completely understanding any requirement of the study, which might compromise the patient's consent and/or the observance of the protocol and the consistent participation to the study.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00199680
Start Date
October 1 2003
Last Update
February 1 2006
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynécologie Obstétrique
Limoges, France, 87000
2
Médecine Nucléaire
Limoges, France, 87000
3
Oncologie Médicale
Limoges, France, 87000